Members of Myositis UK living with myositis have been invited to find out more about taking part in two active clinical trials/studies.
VALOR Study
The VALOR Study is a clinical study sponsored by Priovant Therapeutics for adults (from 18 to 75 years old) with dermatomyositis who are not finding symptom relief with current treatment.
The VALOR Study is evaluating an investigational medicine called brepocitinib to see if it may improve symptoms of dermatomyositis in adults 18 to 74 years old.
Learn more about the study, eligibility and how to take part:
NEPTUNIA
NEPTUNIA clinical research study is sponsored by Merck Healthcare KGaA and for adults (from 18 to 75 years old) who have been diagnosed with DM or PM.
NEPTUNIA will evaluate the efficacy and safety of enpatoran tablets (the “lnvestigational Medication”) that will be administered twice daily.
Enpatoran is designed to potentially block specific cell pathways that may contribute to an overreaction of the immune system in people with myositis.
Learn more about the study, eligibility and how to take part:
